No connection

Search Results

GLPG vs MESO

GLPG
Galapagos NV
NEUTRAL
Price
$28.56
Market Cap
$1.92B
Sector
Healthcare
AI Confidence
80%
MESO
Mesoblast Limited
BEARISH
Price
$14.70
Market Cap
$1.92B
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
GLPG
5.16
MESO
--
Forward P/E
GLPG
-18.18
MESO
-210.0
P/B Ratio
GLPG
0.5
MESO
32.96
P/S Ratio
GLPG
1.72
MESO
29.42
EV/EBITDA
GLPG
-1.95
MESO
-294.48

Profitability

Gross Margin
GLPG
56.02%
MESO
-35.53%
Operating Margin
GLPG
88.0%
MESO
-55.16%
Profit Margin
GLPG
28.85%
MESO
-144.33%
ROE
GLPG
10.42%
MESO
-18.22%
ROA
GLPG
8.87%
MESO
-6.16%

Growth

Revenue Growth
GLPG
1093.2%
MESO
1526.8%
Earnings Growth
GLPG
3036.0%
MESO
--

Financial Health

Debt/Equity
GLPG
0.0
MESO
0.24
Current Ratio
GLPG
20.14
MESO
1.58
Quick Ratio
GLPG
19.96
MESO
1.35

Dividends

Dividend Yield
GLPG
--
MESO
--
Payout Ratio
GLPG
0.0%
MESO
0.0%

AI Verdict

GLPG NEUTRAL

GLPG presents a classic 'value trap' profile: while the Graham Number ($84.09) and Intrinsic Value ($163.14) suggest massive undervaluation, the Piotroski F-Score of 2/9 indicates severely weak fundamental health. The company boasts a pristine balance sheet with zero debt and an extraordinary current ratio of 20.14, yet the market is pricing it at a 66% discount to its defensive fair value. This discrepancy, combined with a negative forward P/E and a 0/100 technical trend, suggests the market anticipates a significant reversal of recent growth spikes.

Strengths
Zero debt (Debt/Equity: 0.00)
Extreme short-term liquidity (Current Ratio: 20.14)
Deeply undervalued relative to book value (P/B: 0.50)
Risks
Weak fundamental trend (Piotroski F-Score: 2/9)
Negative forward earnings expectations (Forward P/E: -18.18)
Strong bearish technical momentum (Technical Trend: 0/100)
MESO BEARISH

MESO presents a high-risk profile characterized by a stable but mediocre Piotroski F-Score of 4/9 and a complete absence of deterministic value markers like the Graham Number. While revenue growth is explosive (1526.8%), the company suffers from a catastrophic negative gross margin of -35.53%, meaning it loses money on its core product delivery. The valuation is extreme, with a Price-to-Book ratio of 32.96 and a Price-to-Sales ratio of 29.42, indicating the stock is priced for perfection despite consistent quarterly losses over several years.

Strengths
Explosive year-over-year revenue growth of 1526.80%
Low Debt-to-Equity ratio (0.24) indicating minimal leverage
Healthy short-term liquidity with a Current Ratio of 1.58
Risks
Negative Gross Margin (-35.53%) indicates a fundamentally flawed cost structure
Extreme valuation multiples (P/B 32.96, P/S 29.42) far exceeding industry norms
Chronic lack of profitability with negative earnings across 25 consecutive quarters

Compare Another Pair

GLPG vs MESO: Head-to-Head Comparison

This page compares Galapagos NV (GLPG) and Mesoblast Limited (MESO) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile